A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
St. Jude Children's Research Hospital
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Memorial Sloan Kettering Cancer Center